|
[1]
|
Mills Sr, J.L. (2003) Buerger’s Disease in the 21st Century: Diagnosis, Clinical Features and Therapy. Seminars in Vas-cular Surgery, 16, 179-189. [Google Scholar] [CrossRef]
|
|
[2]
|
王嘉桔, 赵文光, 孙思翘, 等. 血栓闭塞性脉管炎的发病变迁(百年回顾之一) [J]. 中国血管外科杂志(电子版), 2009, 1(1): 9-12.
|
|
[3]
|
郑萍. 血栓闭塞性脉管炎的病因和发病机理[J]. 北方医学, 1983(5): 13-15.
|
|
[4]
|
郑萍, 傅培彬, 王万超, 等. 血栓闭塞性脉管炎(TAO)的免疫功能状态研究[J]. 上海免疫学杂志, 1985(3): 146-151.
|
|
[5]
|
王万超, 谢雅莉, 李萱茂, 等. 直接免疫荧光技术对人体T淋巴细胞表面免疫球蛋白检测的探讨及应用[J]. 中华医学检验杂志, 1982, 5(2): 74-76.
|
|
[6]
|
马宝骊, 王一飞, 王万超, 等. 医学免疫学[M]. 第1版. 上海: 上海同济大学出版社, 1987: 164-1718.
|
|
[7]
|
Pokorny, J. and Jezkova, Z. (1962) Significance of Immunological Studies in Peripheral Obliterating Vascular Diseases. Circulation Research, 11, 961-965. [Google Scholar] [CrossRef]
|
|
[8]
|
王嘉桔, 赵文光, 郑萍, 等. 对血栓闭塞性脉管炎的新认识[J]. 吉林医学, 1886, 7(5): 53.
|
|
[9]
|
杨博华, 张述刚, 李令根, 等. 关于血栓闭塞性脉管炎病人体液免疫功能的研究[J]. 中医药信息, 1987(5): 34-36.
|
|
[10]
|
Eichhorn, J., Sina, D., Lindschau, C., et al. (1995) Antiendotheluial Cell Antibodies in Thromboangiitis Obliterans. The American Journal of the Medical Sciences, 315, 17-23.
|
|
[11]
|
Halacheva, K.S., Manolova, I.M., Petkov, D.P., et al. (1998) Study of An-ti-Neutrophil Disease. Scandinavian Journal of Immunology, 48, 544-550.
|
|
[12]
|
王俊英, 蒋米尔, 薛莲. 血栓闭塞性脉管炎患者抗磷脂蛋白抗体检测及意义[J]. 上海医学, 1997(5): 280-282.
|
|
[13]
|
de Godoy, J.M.P. and Braile, D.M. (2009) Burger’s Disease and Anticardiolipin Antibodies. Journal of Cardiovascular Medicine, 10, 792-794. [Google Scholar] [CrossRef]
|
|
[14]
|
Klein-Weigel, P.F., Bimmler, M., Hempel, P., et al. (2014) G-Protin Coupled Recepter Auto-Antiboties in Thromboangiitis Obliterans (Buerger’s) and Their Removal by Immuno-adsorption. Vasa, 43, 347-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Dellalibera-Joviliano, R., Joviliano, E.E., Silva, J.S. and Evora, P.R.B. (2012) Activation of Cytokines Corroborate with Development of Inflammation and Autoimmunity in Thrombo-angiitis Obliterans Patients. Clinical and Experimental Immunology, 170, 28-35. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Halacheva, K., Gulubova, M.V., Manolova, I. and Petkov, D. (2002) Expression of ICAM-1, VCAM-1, E-Selectin and TNF-α on the Endothelium of Femoral and Iliac Arteries in Thromboangiitis Obliterans. Acta Histochemica, 104, 177-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
伏祥茂, 景在平, 郭峰. 血栓闭塞性脉管炎患者红细胞免疫功能及调节因子的研究[J]. 上海医学, 1997(7): 403-404.
|
|
[18]
|
郭轶, 代远斌. 血栓闭塞性脉管炎患者血管壁的免疫病理学研究[J]. 重庆医科大学学报, 2009, 34(12): 1683-1685.
|
|
[19]
|
Baumann, G., Stangl, V., Klein-Weigel, P., et al. (2011) Successful Treatment of Thromboangiitis Obliterans (Burger’ s Disease) with Immunoadsorption: Results of a Pilot Study. Clinical Research in Cardiology, 100, 683-690. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Klein-Weigel, P., Volz, T.S., Gutsche-Petrak, B., et al. (2016) Immunoadsorption in Buerger’s Disease (Thromboangiitis Obliterans): A Promising Therapeutic Option: Result of Con-secutive Patient COHORT Treated in Clinical Routine Care. Lupus Open Access, 1, Article 114. [Google Scholar] [CrossRef]
|
|
[21]
|
尹悦, 李莉. IgE与自身免疫性疾病关系的研究进展[J]. 中华检验医学杂志, 2018, 41(3): 242-245.
|
|
[22]
|
Kimura, A., Kohayashi, Y., et al. (1998) MICA Gene Polymorphism in Takayasu’s Arteritis and Buerger’s Disease. International Journal of Cardiology, 66, S107-S113. [Google Scholar] [CrossRef]
|
|
[23]
|
Fakour, F. and Fazeli, B. (2019) Visceral Bed Involvement in Thromboangiitis Obliterans: A Systematic Review. Vascular Health and Risk Management, 15, 317-353. [Google Scholar] [CrossRef]
|
|
[24]
|
上海第二医学院附属瑞金医院中西医结合脉管炎小组, 上海第二医学院附属瑞金医院内科. 血栓闭塞性脉管炎合并心肌梗塞三例报告[J]. 心脏血管疾病, 1978, 6(1): 19-21.
|
|
[25]
|
Papa, M., Bass, A., Adar, R., et al. (1992) Autoimmune Mechanisms in Thromboangiitis Obliterans (Buerger’s Disease): The Role of Tabacco Antigen and the Majio Histocompatibility Complex. Surgery, 111, 527-531.
|
|
[26]
|
孙凯, 冯琦, 窦科峰. 性激素免疫调节效应与疾病发生的关系[J]. 中华预防医学杂志, 2002, 36(6): 421-423.
|
|
[27]
|
郑萍, 陈赛娟, 邵慧珍. 血栓闭塞性脉管炎血液高凝狀态的研究[J]. 中华医学杂志(英文版), 1989, 102(1): 67-71.
|